Back
FibroGen Vs. Emergent BioSolutions Industry Stock Comparison
Sell
27
FGEN
FibroGen
Last Price:
1.13
Seasonality Move:
-2.91%
Buy
59
EBS
Emergent BioSolutions
Last Price:
3.89
Seasonality Move:
4.47%
Sell
27
FibroGen (FGEN)
is a Sell
Is FibroGen a Buy, Sell or Hold?
- The current FibroGen [FGEN] share price is $1.14. The Score for FGEN is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- FGEN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
59
Emergent BioSolutions (EBS)
is a Buy
Is Emergent BioSolutions a Buy, Sell or Hold?
- The current Emergent BioSolutions [EBS] share price is $3.89. The Score for EBS is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- EBS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
FGEN Stock Price Chart
EBS Stock Price Chart
What is Emergent BioSolutions's stock price today?
-
The Emergent BioSolutions share price today is $3.89
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EBS is experiencing buying pressure, which is a positive indicator for future bullish movement.
FGEN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.19 | Sell |
| Relative Strength Index (14 RSI): | 37.02 | Sell |
| Chaikin Money Flow: | -349515 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.01 - 1.67) | Sell |
| Bollinger Bands (100): | (0.87 - 2.11) | Sell |
EBS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.13 | Buy |
| Relative Strength Index (14 RSI): | 78.63 | Buy |
| Chaikin Money Flow: | 11327576 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.78 - 2.66) | Buy |
| Bollinger Bands (100): | (1.78 - 2.74) | Buy |
FGEN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.09 | Buy |
| 20-day SMA: | 1.21 | Sell |
| 50-day SMA: | 1.72 | Sell |
| 200-day SMA: | 1.22 | Sell |
| 8-day EMA: | 1.13 | Buy |
| 20-day EMA: | 1.28 | Sell |
| 50-day EMA: | 1.5 | Sell |
| 200-day EMA: | 3.22 | Sell |
EBS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.37 | Buy |
| 20-day SMA: | 2.21 | Buy |
| 50-day SMA: | 2.48 | Buy |
| 200-day SMA: | 3.02 | Buy |
| 8-day EMA: | 2.63 | Buy |
| 20-day EMA: | 2.36 | Buy |
| 50-day EMA: | 2.32 | Buy |
| 200-day EMA: | 4.09 | Sell |
FibroGen Earnings Growth & FGEN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.40 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.41 per share, and an increase next year of $1.84 per share.
Emergent BioSolutions Earnings Growth & EBS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.60 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.87 per share, and an increase next year of $0.85 per share.
FibroGen Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Emergent BioSolutions Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||